Comparison of Two Treatment Regimens of Helicobacter Pylori Infection

Launched by REHMAN MEDICAL INSTITUTE - RMI · Jun 11, 2025

Keywords

ClinConnect Summary

This clinical trial is designed to compare two different treatment options for Helicobacter pylori infection, which is a common stomach infection that can cause ulcers. The trial will look at how effective two types of antibiotics—clarithromycin and levofloxacin—are in treating this infection. Patients who test positive for H. pylori will be divided into two groups: one group will receive treatment with clarithromycin, while the other group will receive levofloxacin. The main goal is to find out which antibiotic regimen works better.

To participate in this study, you must be at least 12 years old and have tested positive for H. pylori using a stool test. However, if you have a known allergy to penicillin or certain other antibiotics, or if you have specific heart conditions, you won’t be eligible to join. If you do participate, you can expect to receive one of the two treatments and be monitored for how well it works. This trial is currently not yet recruiting participants, but it aims to help improve the treatment of H. pylori infections in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • All patients who tested positive on stool antigen will be included.
• Exclusion Criteria:
• • patients under 12 years old. Patients who have penicillin allergy.
• • Patients who have underlying dysrhythmia forbidding the use of macrolide.
• • Patient who have hypersensitivity to any of these antibiotics.